The Predictive Values of White Blood Cell Indices (Lymphocyte and Eosinophilic Granulocyte) for Heart Failure in Acute Coronary Syndrome Patients Following Percutaneous Coronary Intervention: A Prospective Cohort Study

References

• Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. Lancet. 2022;399(10332):1347–1358. doi:10.1016/S0140-6736(21)02391-6
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67–e492. doi:10.1161/CIR.0000000000000558
   PubMed Web of Science ®Google Scholar
• Shen C, Ge J. Epidemic of cardiovascular disease in china: current perspective and prospects for the future. Circulation. 2018;138(4):342–344. doi:10.1161/CIRCULATIONAHA.118.033484
   PubMed Web of Science ®Google Scholar
• Libby P, Loscalzo J, Ridker PM, et al. Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week. J Am Coll Cardiol. 2018;72(17):2071–2081. doi:10.1016/j.jacc.2018.08.1043
   PubMed Web of Science ®Google Scholar
• Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013;13(1):34–45. doi:10.1038/nri3345
   PubMed Web of Science ®Google Scholar
• De Luca G, Verdoia M, Suryapranata H. Benefits from intracoronary as compared to intravenous Abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials. Atherosclerosis. 2012;222(2):426–433. doi:10.1016/j.atherosclerosis.2012.02.041
   PubMed Web of Science ®Google Scholar
• Heymans S, Hirsch E, Anker SD, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009;11(2):119–129. doi:10.1093/eurjhf/hfn043
   PubMed Web of Science ®Google Scholar
• Pfister R, Sharp SJ, Luben R, Wareham NJ, Khaw KT. Differential white blood cell count and incident heart failure in men and women in the EPIC-Norfolk study. Eur Heart J. 2012;33(4):523–530. doi:10.1093/eurheartj/ehr457
   PubMed Web of Science ®Google Scholar
• Bekwelem W, Lutsey PL, Loehr LR, et al. White blood cell count, C-reactive protein, and incident heart failure in the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol. 2011;21(10):739–748. doi:10.1016/j.annepidem.2011.06.005
   PubMed Web of Science ®Google Scholar
• Rana JS, Boekholdt SM, Ridker PM, et al. Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk prospective population study. J Intern Med. 2007;262(6):678–689. doi:10.1111/j.1365-2796.2007.01864.x
   PubMed Web of Science ®Google Scholar
• Forteza MJ, Trapero I, Hervas A, et al. Apoptosis and mobilization of lymphocytes to cardiac tissue is associated with myocardial infarction in a reperfused porcine model and infarct size in post-PCI patients. Oxid Med Cell Longev. 2018;2018:1975167. doi:10.1155/2018/1975167
   PubMed Web of Science ®Google Scholar
• Husser O, Bodi V, Sanchis J, et al. White blood cell subtypes after STEMI: temporal evolution, association with cardiovascular magnetic resonance--derived infarct size and impact on outcome. Inflammation. 2011;34(2):73–84. doi:10.1007/s10753-010-9209-0
   PubMed Web of Science ®Google Scholar
• Zhang L, Xu C, Liu J, et al. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study. Cardiovasc Diabetol. 2019;18(1):52. doi:10.1186/s12933-019-0858-5
   PubMed Web of Science ®Google Scholar
• Zhang Z, Gao S, Dong M, et al. Relationship between red blood cell indices (MCV, MCH, and MCHC) and major adverse cardiovascular events in anemic and nonanemic patients with acute coronary syndrome. Dis Markers. 2022;2022:2193343. doi:10.1155/2022/2193343
   PubMed Web of Science ®Google Scholar
• Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102(6):653–657. doi:10.1016/j.amjcard.2008.05.006
   PubMed Web of Science ®Google Scholar
• Strassheim D, Dempsey EC, Gerasimovskaya E, Stenmark K, Karoor V. Role of inflammatory cell subtypes in heart failure. J Immunol Res. 2019;2019:2164017. doi:10.1155/2019/2164017
   PubMed Web of Science ®Google Scholar
• Kallikourdis M, Martini E, Carullo P, et al. T cell costimulation blockade blunts pressure overload-induced heart failure. Nat Commun. 2017;8:14680. doi:10.1038/ncomms14680
   PubMed Web of Science ®Google Scholar
• Gröschel C, Sasse A, Monecke S, et al. CD8(+)-T cells with specificity for a model antigen in cardiomyocytes can become activated after transverse aortic constriction but do not accelerate progression to heart failure. Front Immunol. 2018;9:2665. doi:10.3389/fimmu.2018.02665
   PubMed Web of Science ®Google Scholar
• Zhao RX, Li WJ, Lu YR, et al. Increased peripheral proinflammatory T helper subsets contribute to cardiovascular complications in diabetic patients. Mediators Inflamm. 2014;2014:596967. doi:10.1155/2014/596967
   PubMed Web of Science ®Google Scholar
• Dumitriu IE. The life (and death) of CD4+ CD28(null) T cells in inflammatory diseases. Immunology. 2015;146(2):185–193. doi:10.1111/imm.12506
   PubMed Web of Science ®Google Scholar
• Ogbogu PU, Rosing DR, Horne MK. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007;27(3):457–475. doi:10.1016/j.iac.2007.07.001
   PubMed Web of Science ®Google Scholar
• Diny NL, Baldeviano GC, Talor MV, et al. Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy. J Exp Med. 2017;214(4):943–957. doi:10.1084/jem.20161702
   PubMed Web of Science ®Google Scholar
• Cheung CC, Constantine M, Ahmadi A, Shiau C, Chen LYC. Eosinophilic Myocarditis. Am J Med Sci. 2017;354(5):486–492. doi:10.1016/j.amjms.2017.04.002
   PubMed Web of Science ®Google Scholar
• Marx C, Novotny J, Salbeck D, et al. Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps. Blood. 2019;134(21):1859–1872. doi:10.1182/blood.2019000518
   PubMed Web of Science ®Google Scholar
• Jacobsen EA, Taranova AG, Lee NA, Lee JJ. Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? J Allergy Clin Immunol. 2007;119(6):1313–1320. doi:10.1016/j.jaci.2007.03.043
   PubMed Web of Science ®Google Scholar
• Jiang P, Wang DZ, Ren YL, Cai JP, Chen BX. Significance of eosinophil accumulation in the thrombus and decrease in peripheral blood in patients with acute coronary syndrome. Coron Artery Dis. 2015;26(2):101–106. doi:10.1097/MCA.0000000000000186
   PubMed Web of Science ®Google Scholar
• Toor IS, Jaumdally R, Lip GY, Millane T, Varma C. Eosinophil count predicts mortality following percutaneous coronary intervention. Thromb Res. 2012;130(4):607–611. doi:10.1016/j.thromres.2012.05.033
   PubMed Web of Science ®Google Scholar
• Shiyovich A, Gilutz H, Plakht Y. White blood cell subtypes are associated with a greater long-term risk of death after acute myocardial infarction. Texas Heart Insti J. 2017;44(3):176–188. doi:10.14503/THIJ-16-5768
   PubMed Web of Science ®Google Scholar
• Konishi T, Funayama N, Yamamoto T, et al. Prognostic value of eosinophil to leukocyte ratio in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. J Atheroscler Thromb. 2017;24(8):827–840. doi:10.5551/jat.37937
   PubMed Web of Science ®Google Scholar